Abbott said that an ongoing multisite clinical study indicated that its rapid COVID-19 test was accurate when detecting the virus nearly 95% of the time. Abbott said that an ongoing multisite ...

Abbott expects the test to be available in emergency rooms and urgent care centers this summer. A blood test designed to aid in the rapid diagnosis of concussions has gained FDA approval.

The rapid tests are produced by Abbott Labs and are called the BinaxNOW COVID-19 Ag Card. There was a prior Abbott rapid test called the ID Now, which had been criticised in some studies for an ...

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying base business ...

Abbott Laboratories is forecasting lower ... but the company saw increased demand for rapid flu, strep and RSV tests.